Assessing The Cost Saving Potential of Introducing Benepali®, An Etanercept Biosimilar, For The Treatment of All Licensed Adult Etanercept Indications In France, Italy And Sweden
Abstract
Authors
E Psachoulia A Bresson K Holmqvist C Negrini